MUMBAI, India, June 13 -- Intellectual Property India has published a patent application (202517039127 A) filed by Trasveda Ltd., Grand Cayman, Cayman Islands, on April 23, for 'compounds with anti-kras mutant tumor activity.'
Inventor(s) include Shang, Erchang; Zhong, Boyu; Zhang, Tony Yantao; Hou, Fuliang; Song, Guanglin; Liu, Shuai; Zheng, Aijun; Wang, Ruixiang; Wang, Longfei; Jiang, Jun; and Dong, Chunlan.
The application for the patent was published on June 13, under issue no. 24/2025.
According to the abstract released by the Intellectual Property India: "The present invention provides compounds having the structure of formula (I) and being capable of being used as a KRAS inhibitor, a pharmaceutical composition comprising the compo...